Your browser doesn't support javascript.
loading
Efficacy and safety of anti-PD-1-based therapy in combination with PARP inhibitors for patients with advanced solid tumors in a real-world setting.
Wu, Zhaozhen; Tao, Haitao; Zhang, Sujie; Wang, Xiao; Ma, Junxun; Li, Ruixin; Liu, Zhefeng; Wang, Jinliang; Cui, Pengfei; Chen, Shixue; Di, Huang; Huang, Ziwei; Zheng, Xuan; Hu, Yi.
Afiliação
  • Wu Z; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Tao H; Beijing Chest Hospital, Beijing, 101149, China.
  • Zhang S; School of Medicine, Nankai Universitiy, Tianjin, 300071, China.
  • Wang X; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Ma J; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Li R; School of Medicine, Oregon Health & Science University, Oregon, 97239-3098, USA.
  • Liu Z; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Wang J; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Cui P; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Chen S; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Di H; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Huang Z; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Zheng X; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Hu Y; School of Medicine, Nankai Universitiy, Tianjin, 300071, China.
Cancer Immunol Immunother ; 70(10): 2971-2980, 2021 Oct.
Article em En | MEDLINE | ID: mdl-33740125
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Poli(ADP-Ribose) Polimerases / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Poli(ADP-Ribose) Polimerases / Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Observational_studies Limite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Cancer Immunol Immunother Assunto da revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha